|
RPG Life Sciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
3795.70 Cr.
|
P/BV
|
6.59
|
Book Value (Rs.)
|
348.32
|
|
52 Week High/Low (Rs.)
|
2725/1733
|
FV/ML
|
8/1
|
P/E(X)
|
32.96
|
|
Bookclosure
|
27/06/2025
|
EPS (Rs.)
|
69.64
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 707.52 | 647.54 | 577.48 | 509.08 | 440.16 |
| Other Operating Revenues | 0.00 | 5.89 | 4.57 | 3.73 | 0.00 |
| Total Operating Revenues | 707.52 | 653.43 | 582.05 | 512.81 | 440.16 |
| | | | | | |
| Other Income | 25.54 | 12.68 | 7.21 | 4.80 | 2.99 |
| Total Revenue | 733.06 | 666.11 | 589.26 | 517.61 | 443.15 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 135.98 | 110.26 | 120.65 | 86.12 | 88.13 |
| Purchase Of Stock-In Trade | 138.10 | 95.14 | 61.18 | 92.05 | 78.90 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -21.99 | 8.61 | 2.70 | -7.30 | -25.21 |
| Employee Benefit Expenses | 141.48 | 126.14 | 132.15 | 117.06 | 99.97 |
| Finance Costs | 0.89 | 0.62 | 0.45 | 0.31 | 0.52 |
| Depreciation And Amortisation Expenses | 21.48 | 21.43 | 17.07 | 15.50 | 15.66 |
| Other Expenses | 166.82 | 153.63 | 137.22 | 122.19 | 112.01 |
| Total Expenses | 582.76 | 515.83 | 471.42 | 425.93 | 369.98 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 150.30 | 150.28 | 117.84 | 91.68 | 73.17 |
| | | | | | |
| Exceptional Items | 3.90 | 82.60 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 154.20 | 232.88 | 117.84 | 91.68 | 73.17 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 39.03 | 49.69 | 32.54 | 24.35 | 22.76 |
| Deferred Tax | 0.00 | -0.05 | -2.36 | -0.31 | -1.07 |
| Total Tax Expenses | 39.03 | 49.64 | 30.18 | 24.04 | 21.69 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 115.17 | 183.24 | 87.66 | 67.64 | 51.48 |
| | | | | | |
| Profit/Loss From Continuing Operations | 115.17 | 183.24 | 87.66 | 67.64 | 51.48 |
| | | | | | |
| Profit/Loss For The Period | 115.17 | 183.24 | 87.66 | 67.64 | 51.48 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 69.64 | 110.80 | 53.01 | 40.90 | 31.13 |
| Diluted EPS (Rs.) | 69.64 | 110.80 | 53.01 | 40.90 | 31.13 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 26.46 | 19.85 | 15.88 | 11.91 |
| Equity Dividend Rate (%) | 0.00 | 300.00 | 200.00 | 150.00 | 120.00 |
